Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- University of North Carolina, Chapel Hill
- Study ID
- NCT05693922
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Delta-beta cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MC — DEVICEDelta-beta stimulation will be delivered via the NeuroConn DC-STIMULATOR MC, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.
- Single-session behavioral activation — BEHAVIORALParticipants will take part in a single-session behavioral activation (BA) intervention. This intervention was adapted from standard BA protocols for the treatment of depression to be completed in a single, 90-minute session. This intervention will have 4 main components based on prior protocols: * Treatment overview and rationale * Tracking of daily activities * Exploration of values * Planning/scheduling activities
- Active sham cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MC — DEVICEActive sham stimulation will be delivered via the NeuroConn DC-STIMULATOR MC, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.
Study Details
Investigating whether delta-beta cross-frequency transcranial alternating current stimulation can augment the effects of a single session of behavioral activation in participants with major depressive disorder.
Key Dates
- Start date
- Feb 9, 2023
- Status verified
- Jan 2024
- Primary completion
- May 22, 2024
- Completion
- May 22, 2024
Study Design
- Enrollment
- 30 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Delta-beta tACSParticipants will receive a single session intervention of behavioral activation (BA) psychotherapy. Stimulation will be delivered via the NeuroConn DC-STIMULATOR MC at 1 milliampere (mA) zero-to-peak amplitude at the target electrodes and 2 mA zero to-peak amplitude at the return electrode. The tACS will be delivered using the cross-frequency stimulation waveform delta-beta (3-20Hz).
- Sham Comparator: Active-sham tACSParticipants will receive a single session intervention of behavioral activation (BA) psychotherapy. The active sham condition includes brief stimulation, mimicking the skin sensations associated with tACS, assisting with blinding the participant's assignment.
Primary Outcome Measure
Clinician-rated Depressive Symptoms [ Time Frame: Baseline, 2 weeks post treatment ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | - |
Find similar trials in Chapel Hill, NC
By condition
By specialty
By research site
Related Studies
- Study of ALTO-300 in MDDPHASE2 · Recruiting · Alto Neuroscience · Phoenix, Arizona
- A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPHASE4 · Recruiting · Axsome Therapeutics, Inc. · Bellflower, California
- "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"PHASE3 · Recruiting · Cybin IRL Limited · Phoenix, Arizona
- Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of DepressionPHASE4 · Recruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina